Heron Therapeutics
Stock Forecast, Prediction & Price Target
Heron Therapeutics Financial Estimates
Heron Therapeutics Revenue Estimates
Heron Therapeutics EBITDA Estimates
Heron Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $86.34M N/A | $107.67M 24.69% | $127.04M 17.99% | Avg: $173.38M Low: $173.38M High: $173.38M avg. 36.47% | Avg: $205.22M Low: $205.22M High: $205.22M avg. 18.36% | Avg: $244.4M Low: $244.4M High: $244.4M avg. 19.08% | Avg: $288.76M Low: $288.76M High: $288.76M avg. 18.15% |
Net Income
% change YoY
| $-220.68M N/A | $-182.02M 17.51% | $-110.55M 39.26% | Avg: $-1.95M Low: $-1.95M High: $-1.95M avg. 98.22% | Avg: $20.86M Low: $20.86M High: $20.86M avg. 1165.37% | Avg: $45.58M Low: $45.58M High: $45.58M avg. 118.44% | Avg: $62.85M Low: $62.85M High: $62.85M avg. 37.87% |
EBITDA
% change YoY
| $-213.20M N/A | $-166.36M 21.96% | $-103.79M 37.61% | Avg: $-168.11M Low: $-168.11M High: $-168.11M avg. -61.96% | Avg: $-198.98M Low: $-198.98M High: $-198.98M avg. -18.36% | Avg: $-236.96M Low: $-236.96M High: $-236.96M avg. -19.08% | Avg: $-279.98M Low: $-279.98M High: $-279.98M avg. -18.15% |
EPS
% change YoY
| -$2.24 N/A | -$1.67 25.44% | -$0.8 52.09% | Avg: -$0.01 Low: -$0.01 High: -$0.01 avg. 98.22% | Avg: $0.15 Low: $0.15 High: $0.15 avg. 1165.37% | Avg: $0.33 Low: $0.33 High: $0.33 avg. 118.44% | Avg: $0.46 Low: $0.46 High: $0.46 avg. 37.87% |
Operating Expenses
% change YoY
| $256.55M N/A | $222.05M -13.44% | $120.65M -45.66% | Avg: $192.41M Low: $192.41M High: $192.41M avg. 59.46% | Avg: $227.74M Low: $227.74M High: $227.74M avg. 18.36% | Avg: $271.21M Low: $271.21M High: $271.21M avg. 19.08% | Avg: $320.45M Low: $320.45M High: $320.45M avg. 18.15% |
FAQ
What is Heron Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 354.98% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -1.95M, average is -1.95M and high is -1.95M.
What is Heron Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 23.02% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $173.38M, average is $173.38M and high is $173.38M.
What is Heron Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 354.98% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.01, average is -$0.01 and high is $-0.01.